- Home
- ATRA vs AVX Comparison
ATRA vs AVX Comparison
Compare ATRA & AVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATRA | AVX |
|---|---|---|
| Founded | 2012 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.4M | 119.2M |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ATRA | AVX |
|---|---|---|
| Price | $4.55 | $1.68 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 610.3K | 167.3K |
| Earning Date | 03-06-2026 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.97 | N/A |
| Revenue | ★ $151,930,000.00 | $1,319,011.00 |
| Revenue This Year | N/A | $530,767.50 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.31 | ★ N/A |
| Revenue Growth | 51.27 | ★ 8001.54 |
| 52 Week Low | $4.25 | $1.12 |
| 52 Week High | $19.15 | $25.38 |
Technical Indicators
Market Signals| Indicator | ATRA | AVX |
|---|---|---|
| Relative Strength Index (RSI) | 23.81 | N/A |
| Support Level | $4.25 | N/A |
| Resistance Level | $5.19 | N/A |
| Average True Range (ATR) | 1.63 | 0.00 |
| MACD | -1.54 | 0.00 |
| Stochastic Oscillator | 2.07 | 0.00 |
Price Performance
Historical ComparisonAbout ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
About AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a public company offering investors regulated access to the Avalanche (AVAX) ecosystem. By integrating the reliability of U.S. capital markets with the growth potential of decentralized finance, it seeks to create a bridge between traditional and digital finance. The company focuses on building a digital-asset treasury, fostering innovation, and investing in decentralized financial technologies that benefit from the Avalanche network.